Translational Approach to Antitumor Drugs
This special issue belongs to the section "Medicinal Chemistry".
Special Issue Information
Dear Colleagues,
We are facing an overwhelming need for better cancer drugs. The development of these new drugs involves a broad translational approach to various treatment methods and types, such as small molecules, newly synthesized organic compounds, synthetic or purified natural products originating from the sea or on land, medical devices including inorganic compounds, etc. This Special Issue addresses a broad approach to new anticancer drugs that includes chemical synthesis, extraction and purification, and an in silico approach. This issue aims to provide a forum for the dissemination of the latest information on some new potential anticancer drugs, and methods of testing their success.
Prof. Dr. Krešimir Pavelić
Prof. Dr. Sandra Kraljevic Pavelic
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- In silico design and prediction
- Conjugates of purine and purine isosteres with ferrocene: evaluation of ADME, antitumor, and antioxidant properties
- Benzothiazole and benzimidazole derivatives, anticancer effect
- Pharmacological modulation of sphingolipid metabolism, chemoresistance, colon cancer
- Silver(I) complexes with dichloro- and dibromo-substituted derivatives of pyridine, antibacterial and antitumor activity
- Exosomes, liver, proteomics
- Structural diversity, biological activity, synthesis, natural products
- Natural compounds or derivatives in cancer treatment
- Chemotherapy-induced cancer polyneuropathy, ion exchange therapy, zeolite
- Epigenetics and cancer treatment
- Early non-invasive gastric cancer detection study using the serum pepsinogen test method
- Breast cancer patients, cancer phenotypes Ki-67, predictors of tissue invasion, multivariate adaptive regression splines (MARS)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Published Papers
Molecules - ISSN 1420-3049